Tzield, approved by the FDA in 2022, is now available as an option for patients with Stage-2 Type 1 diabetes.
The Barbara Davis Center Pediatric Clinic and Children's Hospital Colorado share a long-standing collaboration focused on delivering exceptional care to children, adolescents, and young adults with diabetes and other endocrine conditions. This partnership is reflected in the consistently strong national recognition of Children's Hospital Colorado in U.S. News and World Report rankings for pediatric diabetes and endocrinology. As the largest center in the United States caring for children, adolescents, and young adults with type 1 diabetes, the BDC Pediatric Clinic provides care for over 4,000 patients across Colorado and neighboring states. A substantial portion of the diabetes related clinical data supporting the ranking reflects the care delivered through the BDC Pediatric Clinic. These contributions complement the important work of Children's Colorado's diabetes and endocrinology programs, including care in Colorado Springs, youth type 2 diabetes programs, and hospital-wide measures of quality and nursing excellence. Together, this integrated model brings multidisciplinary expertise, innovative therapies, and a shared commitment to improving outcomes for children and families across the region.